Adolescent Anabolic-Androgenic Steroid Use in Association With Other Drug Use, Injection Drug Use, and Team Sport Participation

References

• Bahrke, M. S., Yesalis, C. E., Kopstein, A. N., & Stephens, J. A. (2000). Risk factors associated with anabolic-androgenic steroid use among adolescents. Sports Medicine, 29(6), 397–405.
   PubMed Web of Science ®Google Scholar
• Bernstein, S. L., & D’Onofrio, G. (2017). Screening, treatment initiation, and referral for substance use disorders. Addiction Science & Clinical Practice, 12(1), 18. https://doi.org/10.1186/s13722-017-0083-z
   PubMedGoogle Scholar
• Blashill, A. J., Calzo, J. P., Griffiths, S., & Murray, S. B. (2017). Anabolic steroid misuse among US adolescent boys: Disparities by sexual orientation and race/ethnicity. American Journal of Public Health, 107(2), 319–321. https://doi.org/10.2105/AJPH.2016.303566
   PubMed Web of Science ®Google Scholar
• Boyce, E. G. (2003). Use and effectiveness of performance-enhancing substances. Journal of Pharmacy Practice, 16(1), 22–36. https://doi.org/10.1177/0897190002239630
   Google Scholar
• Brighthaupt, S.-C., Schneider, K. E., Johnson, J. K., Jones, A. A., & Johnson, R. M. (2019). Trends in adolescent heroin and injection drug use in nine urban centers in the U.S., 1999-2017. J Adolesc Health, 65(2), 210–215. https://doi.org/10.1016/j.jadohealth.2019.03.026
   PubMed Web of Science ®Google Scholar
• Elkins, R. L., King, K., Nabors, L. A., & Vidourek, R. (2016). School and parent factors, sport participation, and adolescent steroid use. Research Quarterly for Exercise and Sport, 87(S2), A74.
   Google Scholar
• Gfroerer, J., Bose, J., Kroutil, L., Lopez, M., & Kann, L. (2012). Methodological considerations in estimating adolescent substance use. Proceedings of the Joint Statistical Meetings, Section on Survey Research Methods, 4127–4140.
   Google Scholar
• Harrell, P. T., Mancha, B. E., Petras, H., Trenz, R. C., & Latimer, W. W. (2012). Latent classes of heroin and cocaine users predict unique HIV/HCV risk factors. Drug and Alcohol Dependence, 122(3), 220–227. https://doi.org/10.1016/j.drugalcdep.2011.10.001
   PubMed Web of Science ®Google Scholar
• Hathaway, A. D., Comeau, N. C., & Erickson, P. G. (2011). Cannabis normalization and stigma: Contemporary practices of moral regulation. Criminology & Criminal Justice, 11(5), 451–469. https://doi.org/10.1177/1748895811415345
   Web of Science ®Google Scholar
• Horwitz, H., Andersen, J., & Dalhoff, K. (2019). Health consequences of androgenic anabolic steroid use. Journal of Internal Medicine, 285(3), 333–340. https://doi.org/10.1111/joim.12850
   PubMed Web of Science ®Google Scholar
• Jampel, J. D., Murray, S. B., Griffiths, S., & Blashill, A. J. (2016). Self-perceived weight and anabolic steroid misuse among US adolescent boys. Journal of Adolescent Health, 58(4), 397–402. https://doi.org/10.1016/j.jadohealth.2015.10.003
   PubMed Web of Science ®Google Scholar
• Kanayama, G., Brower, K. J., Wood, R. I., Hudson, J. I., & Pope, H. G. (2010). Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implications. Drug and Alcohol Dependence, 109(1–3), 6–13. https://doi.org/10.1016/j.drugalcdep.2010.01.011
   PubMed Web of Science ®Google Scholar
• Kann, L., McManus, T., Harris, W. A., Shanklin, S. L., Flint, K. H., Queen, B., Lowry, R., Chyen, D., Whittle, L., Thornton, J., Lim, C., Bradford, D., Yamakawa, Y., Leon, M., Brener, N., & Ethier, K. A. (2018). Youth risk behavior surveillance – United States, 2017. Morbidity and Mortality Weekly Report. Surveillance Summaries, 67(8), 1–114. https://doi.org/10.15585/mmwr.ss6708a1
   PubMed Web of Science ®Google Scholar
• Kerr, J. M., & Congeni, J. A. (2007). Anabolic-androgenic steroids: Use and abuse in pediatric patients. Pediatric Clinics of North America, 54(4), 771–785. https://doi.org/10.1016/j.pcl.2007.04.010
   PubMed Web of Science ®Google Scholar
• Komoroski, E. M., & Rickert, V. I. (1992). Adolescent body image and attitudes to anabolic steroid use. American Journal of Diseases of Children, 146(7), 823–828. https://doi.org/10.1001/archpedi.1992.02160190055019
   PubMedGoogle Scholar
• Miech, R. A., Johnston, L. D., O’Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2019). Monitoring the future: National Survey Results on Drug Use, 1975–2019. https://nida.nih.gov/drug-topics/trends-statistics/monitoring-future
   Google Scholar
• Miller, K. E., Barnes, G. M., Sabo, D. F., Melnick, M. J., & Farrell, M. P. (2002). Anabolic-androgenic steroid use and other adolescent problem behaviors: Rethinking the male athlete assumption. Sociological Perspectives, 45(4), 467–489. https://doi.org/10.1525/sop.2002.45.4.467
   Web of Science ®Google Scholar
• Miller, K. E., Hoffman, J. H., Barnes, G. M., Sabo, D., Melnick, M. J., & Farrell, M. P. (2005). Adolescent anabolic steroid use, gender, physical activity, and other problem behaviors*. Substance Use & Misuse, 40(11), 1637–1657. https://doi.org/10.1080/10826080500222727
   PubMed Web of Science ®Google Scholar
• Morley, K. I., Lynskey, M. T., Moran, P., Borschmann, R., & Winstock, A. R. (2015). Polysubstance use, mental health and high-risk behaviours: Results from the 2012 Global Drug Survey. Drug and Alcohol Review, 34(4), 427–437. https://doi.org/10.1111/dar.12263
   PubMed Web of Science ®Google Scholar
• National Institute on Drug Abuse. (2019). Monitoring the future study: Trends in prevalence of various drugs. https://www.drugabuse.gov/drug-topics/trends-statistics/monitoring-future/monitoring-future-study-trends-in-prevalence-various-drugs.
   Google Scholar
• Pope, H. G., Kanayama, G., Ionescu-Pioggia, M., & Hudson, J. I. (2004). Anabolic steroid users' attitudes towards physicians. Addiction, 99(9), 1189–1194. https://doi.org/10.1111/j.1360-0443.2004.00781.x
   PubMed Web of Science ®Google Scholar
• Rajan, S., Ruggles, K. V., Guarino, H., & Mateu-Gelabert, P. (2018). Heroin use and drug injection among youth also misusing prescription drugs. American Journal of Health Behavior, 42(1), 144–155. https://doi.org/10.5993/AJHB.42.1.14
   PubMed Web of Science ®Google Scholar
• Rich, J., Dickinson, B., Feller, A., Pugatch, D., & Mylonakis, E. (1999). The infectious complications of anabolic-androgenic steroid injection. International Journal of Sports Medicine, 20(8), 563–566. https://doi.org/10.1055/s-1999-8841
   PubMed Web of Science ®Google Scholar
• Roth, A. M., Armenta, R. A., Wagner, K. D., Roesch, S. C., Bluthenthal, R. N., Cuevas-Mota, J., & Garfein, R. S. (2015). Patterns of drug use, risky behavior, and health status among persons who inject drugs living in San Diego, California: a latent class analysis. Substance Use & Misuse, 50(2), 205–214. https://doi.org/10.3109/10826084.2014.962661
   PubMed Web of Science ®Google Scholar
• Schneider, K. E., Brighthaupt, S.-C., Winiker, A. K., Johnson, R. M., Musci, R. J., & Linton, S. L. (2020). Characterizing profiles of polysubstance use among high school students in Baltimore, Maryland: A latent class analysis. Drug and Alcohol Dependence, 211, 108019. https://doi.org/10.1016/j.drugalcdep.2020.108019
   PubMed Web of Science ®Google Scholar
• Schneider, K. E., O'Rourke, A., White, R. H., Park, J. N., Musci, R. J., Kilkenny, M. E., Sherman, S. G., & Allen, S. T. (2020). Polysubstance use in rural West Virginia: Associations between latent classes of drug use, overdose, and take-home naloxone. International Journal of Drug Policy, 76, 102642. https://doi.org/10.1016/j.drugpo.2019.102642
   PubMed Web of Science ®Google Scholar
• Schneider, K. E., White, R. H., Musci, R. J., O'Rourke, A., Kilkenny, M. E., Sherman, S. G., & Allen, S. T. (2020). The relationship between polysubstance injection drug use, HIV risk behaviors, and interest in Pre-Exposure Prophylaxis (PrEP) among people who inject drugs in rural West Virginia. Journal of Studies on Alcohol and Drugs, 81(6), 740–749. https://doi.org/10.15288/jsad.2020.81.740
   PubMed Web of Science ®Google Scholar
• Substance Abuse and Mental Health Services Administration. (2015). Results from the 2014 National Survey on Drug Use and Health: Detailed tables. SAMHSA.
   Google Scholar
• Wu, L.-T., Ling, W., Burchett, B., Blazer, D. G., Yang, C., Pan, J.-J., Reeve, B. B., & Woody, G. E. (2011). Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network. Drug and Alcohol Dependence, 118(2–3), 186–193. https://doi.org/10.1016/j.drugalcdep.2011.03.018
   PubMed Web of Science ®Google Scholar
• Zahnow, R., McVeigh, J., Bates, G., & Winstock, A. R. (2020). Motives and correlates of anabolic-androgenic steroid use with stimulant polypharmacy. Contemporary Drug Problems, 47(2), 118–135. 0091450920919456. https://doi.org/10.1177/0091450920919456
   Google Scholar